A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
- PMID: 35247979
- PMCID: PMC8898410
- DOI: 10.1186/s12872-022-02522-y
A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
Abstract
Background: The incidence of heart failure (HF) has declined in Europe during the past two decades. However, incidence estimates from registry-based studies may vary, partly because they depend on retrospective searches to exclude previous events. The aim of this study was to assess to what extent different lookback periods (LPs) affect temporal trends in incidence, and to identify the minimal acceptable LP. Further, we wanted to estimate temporal trends in incidence and prevalence of HF in a nationwide population, using the minimal acceptable LP.
Methods: We identified all in- and out-patient contacts for HF in Norway during 2008 to 2018 from the Norwegian Patient Registry. To calculate the influence of varying LP on incident cases, we defined 2018 with 10 years of LP as a reference and calculated the relative difference by using one through 9 years of lookback. Temporal trends in incidence rates were estimated with sensitivity analyses applying varying LPs and different case definitions. Standardised incidence rates and prevalence were calculated by applying direct age- and sex-standardization to the 2013 European Standard Population.
Results: The overestimation of incident cases declined with increasing number of years included in the LP. Compared to a 10-year LP, application of 4, 6, and 8 years resulted in an overestimation of incident cases by 13.5%, 6.2% and 2.3%, respectively. Temporal trends in incidence were affected by the number of years in the LP and whether the LP was fixed or varied. Including all available data mislead to conclusions of declining incidence rates over time due to increasing LPs.
Conclusions: When taking the number of years with available data and HF mortality and morbidity into consideration, we propose that 6 years of fixed lookback is sufficient for identification of incident HF cases. HF incidence rates and prevalence increased from 2014 to 2018.
Trial registration: Retrospectively registered.
Keywords: Heart failure; Incidence; Lookback period; NPR; Prevalence; Wash-out period.
© 2022. The Author(s).
Conflict of interest statement
KMO is a PhD-student at the University of Oslo and an employee of Novartis Norway AS. JH was an employee of Novartis Norway AS at the time the study was conducted. SH reports speakers’ honoraria from Bayer, Pfizer/Bristol Myers Squibb, Sanofi, outside the submitted work. SSL and HOM report consultancy fees from Novartis during the conduct of the study; personal fees from Novartis and Takeda, outside the submitted work.
Figures





Similar articles
-
Effect of the Lookback Period's Length Used to Identify Incident Acute Myocardial Infarction on the Observed Trends on Incidence Rates and Survival: Cardiovascular Disease in Norway Project.Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):376-82. doi: 10.1161/CIRCOUTCOMES.114.001703. Epub 2015 Jun 9. Circ Cardiovasc Qual Outcomes. 2015. PMID: 26058719
-
Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016.ESC Heart Fail. 2020 Aug;7(4):1917-1926. doi: 10.1002/ehf2.12773. Epub 2020 Jun 12. ESC Heart Fail. 2020. PMID: 32530563 Free PMC article.
-
Differing Definitions of First-Ever Stroke Influence Incidence Estimates More than Trends: A Study Using Linked Administrative Data.Neuroepidemiology. 2023;57(6):423-432. doi: 10.1159/000534242. Epub 2023 Sep 26. Neuroepidemiology. 2023. PMID: 37751719
-
Burden of heart failure in Flemish general practices: a registry-based study in the Intego database.BMJ Open. 2019 Jan 7;9(1):e022972. doi: 10.1136/bmjopen-2018-022972. BMJ Open. 2019. PMID: 30617099 Free PMC article.
-
Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study.Heart Fail Rev. 2019 Nov;24(6):989-995. doi: 10.1007/s10741-019-09808-y. Heart Fail Rev. 2019. PMID: 31175492 Review.
Cited by
-
Heart Failure and Cardiomyopathies: CT and MR from Basics to Advanced Imaging.Diagnostics (Basel). 2022 Sep 23;12(10):2298. doi: 10.3390/diagnostics12102298. Diagnostics (Basel). 2022. PMID: 36291987 Free PMC article. Review.
-
Impact of observability period on the classification of COPD diagnosis timing among Medicare beneficiaries with lung cancer.PLOS Digit Health. 2024 Oct 22;3(10):e0000633. doi: 10.1371/journal.pdig.0000633. eCollection 2024 Oct. PLOS Digit Health. 2024. PMID: 39436859 Free PMC article.
-
Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020.ESC Heart Fail. 2023 Feb;10(1):405-415. doi: 10.1002/ehf2.14206. Epub 2022 Oct 20. ESC Heart Fail. 2023. PMID: 36266969 Free PMC article.
-
Why has the incidence of heart failure decreased by half in Türkiye?-Authors' reply.Lancet Reg Health Eur. 2023 Oct 28;35:100762. doi: 10.1016/j.lanepe.2023.100762. eCollection 2023 Dec. Lancet Reg Health Eur. 2023. PMID: 37954221 Free PMC article. No abstract available.
-
Direct Health Care Costs Associated With Multiple Sclerosis: A Population-Based Cohort Study in British Columbia, Canada, 2001-2020.Neurology. 2023 Feb 28;100(9):e899-e910. doi: 10.1212/WNL.0000000000201645. Epub 2022 Nov 30. Neurology. 2023. PMID: 36450607 Free PMC article.
References
-
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975. - PubMed
-
- Bleumink GS, Knetsch AM, Sturkenboom MCJM, Straus SMJM, Hofman A, Deckers JW, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: the Rotterdam Study. Eur Heart J. 2004;25(18):1614–1619. - PubMed
-
- Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KKL, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347(18):1397–1402. - PubMed
-
- Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292(3):344–350. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous